Loading...
Positive response to Icotinib in metastatic lung adenocarcinoma with acquiring EGFR Leu792H mutation after AZD9291 treatment: a case report
BACKGROUND: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have been emerged as the standard selection in non-small cell lung cancer (NSCLC) patients with EGFR sensitive mutations. However, primary or acquired resistance to EGFR-TKIs seems inevitable, especially to third-gen...
Saved in:
| Published in: | BMC Cancer |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6368759/ https://ncbi.nlm.nih.gov/pubmed/30736738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5352-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|